Selected research
Industry Research
Tacrolimus Capsules Industry Research Report 2026
Market perspective
The global Tacrolimus Capsules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Tacrolimus Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Tacrolimus Capsules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Tacrolimus Capsules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Tacrolimus Capsules include Sandoz, Zydus, Torrent, Solco Healthcare, Hikma, Glenmark, Camber Pharmaceuticals, Cadista and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Tacrolimus Capsules market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tacrolimus Capsules Market by Company
Sandoz
Zydus
Torrent
Solco Healthcare
Hikma
Glenmark
Camber Pharmaceuticals
Cadista
Boehringer Ingelheim
Aurobindo
Amneal Pharmaceuticals
Alembic
Tacrolimus Capsules Segment by Type
5mg/pill
1mg/pill
0.5mg/pill
Tacrolimus Capsules Segment by Application
Special Clinic
Hospital
Recovery Center
Tacrolimus Capsules Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tacrolimus Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tacrolimus Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tacrolimus Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tacrolimus Capsules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tacrolimus Capsules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tacrolimus Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5mg/pill
- 1mg/pill
- 0.5mg/pill
Applications
- Special Clinic
- Hospital
- Recovery Center
Companies covered
- Sandoz
- Zydus
- Torrent
- Solco Healthcare
- Hikma
- Glenmark
- Camber Pharmaceuticals
- Cadista
- Boehringer Ingelheim
- Aurobindo
- Amneal Pharmaceuticals
- Alembic
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Tacrolimus Capsules Market Size (2021-2032)
- 2.2.2 Global Tacrolimus Capsules Sales (2021-2032)
- 2.2.3 Global Tacrolimus Capsules Market Average Price (2021-2032)
- 2.3 Tacrolimus Capsules by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 5mg/pill
- 2.3.3 1mg/pill
- 2.3.4 0.5mg/pill
- 2.4 Tacrolimus Capsules by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Special Clinic
- 2.4.3 Hospital
- 2.4.4 Recovery Center
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Tacrolimus Capsules Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Tacrolimus Capsules Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Tacrolimus Capsules Revenue of Manufacturers (2021-2026)
- 3.4 Global Tacrolimus Capsules Average Price by Manufacturers (2021-2026)
- 3.5 Global Tacrolimus Capsules Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Tacrolimus Capsules, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Tacrolimus Capsules, Product Type & Application
- 3.8 Global Manufacturers of Tacrolimus Capsules, Established Date
- 3.9 Global Tacrolimus Capsules Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sandoz
- 4.1.1 Sandoz Company Information
- 4.1.2 Sandoz Business Overview
- 4.1.3 Sandoz Tacrolimus Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sandoz Tacrolimus Capsules Product Portfolio
- 4.1.5 Sandoz Recent Developments
- 4.2 Zydus
- 4.2.1 Zydus Company Information
- 4.2.2 Zydus Business Overview
- 4.2.3 Zydus Tacrolimus Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zydus Tacrolimus Capsules Product Portfolio
- 4.2.5 Zydus Recent Developments
- 4.3 Torrent
- 4.3.1 Torrent Company Information
- 4.3.2 Torrent Business Overview
- 4.3.3 Torrent Tacrolimus Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Torrent Tacrolimus Capsules Product Portfolio
- 4.3.5 Torrent Recent Developments
- 4.4 Solco Healthcare
- 4.4.1 Solco Healthcare Company Information
- 4.4.2 Solco Healthcare Business Overview
- 4.4.3 Solco Healthcare Tacrolimus Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Solco Healthcare Tacrolimus Capsules Product Portfolio
- 4.4.5 Solco Healthcare Recent Developments
- 4.5 Hikma
- 4.5.1 Hikma Company Information
- 4.5.2 Hikma Business Overview
- 4.5.3 Hikma Tacrolimus Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hikma Tacrolimus Capsules Product Portfolio
- 4.5.5 Hikma Recent Developments
- 4.6 Glenmark
- 4.6.1 Glenmark Company Information
- 4.6.2 Glenmark Business Overview
- 4.6.3 Glenmark Tacrolimus Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Glenmark Tacrolimus Capsules Product Portfolio
- 4.6.5 Glenmark Recent Developments
- 4.7 Camber Pharmaceuticals
- 4.7.1 Camber Pharmaceuticals Company Information
- 4.7.2 Camber Pharmaceuticals Business Overview
- 4.7.3 Camber Pharmaceuticals Tacrolimus Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Camber Pharmaceuticals Tacrolimus Capsules Product Portfolio
- 4.7.5 Camber Pharmaceuticals Recent Developments
- 4.8 Cadista
- 4.8.1 Cadista Company Information
- 4.8.2 Cadista Business Overview
- 4.8.3 Cadista Tacrolimus Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Cadista Tacrolimus Capsules Product Portfolio
- 4.8.5 Cadista Recent Developments
- 4.9 Boehringer Ingelheim
- 4.9.1 Boehringer Ingelheim Company Information
- 4.9.2 Boehringer Ingelheim Business Overview
- 4.9.3 Boehringer Ingelheim Tacrolimus Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Boehringer Ingelheim Tacrolimus Capsules Product Portfolio
- 4.9.5 Boehringer Ingelheim Recent Developments
- 4.10 Aurobindo
- 4.10.1 Aurobindo Company Information
- 4.10.2 Aurobindo Business Overview
- 4.10.3 Aurobindo Tacrolimus Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Aurobindo Tacrolimus Capsules Product Portfolio
- 4.10.5 Aurobindo Recent Developments
- 4.11 Amneal Pharmaceuticals
- 4.11.1 Amneal Pharmaceuticals Company Information
- 4.11.2 Amneal Pharmaceuticals Business Overview
- 4.11.3 Amneal Pharmaceuticals Tacrolimus Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Amneal Pharmaceuticals Tacrolimus Capsules Product Portfolio
- 4.11.5 Amneal Pharmaceuticals Recent Developments
- 4.12 Alembic
- 4.12.1 Alembic Company Information
- 4.12.2 Alembic Business Overview
- 4.12.3 Alembic Tacrolimus Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Alembic Tacrolimus Capsules Product Portfolio
- 4.12.5 Alembic Recent Developments
5 Global Tacrolimus Capsules Market Scenario by Region
- 5.1 Global Tacrolimus Capsules Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Tacrolimus Capsules Sales by Region: 2021-2032
- 5.2.1 Global Tacrolimus Capsules Sales by Region: 2021-2026
- 5.2.2 Global Tacrolimus Capsules Sales by Region: 2027-2032
- 5.3 Global Tacrolimus Capsules Revenue by Region: 2021-2032
- 5.3.1 Global Tacrolimus Capsules Revenue by Region: 2021-2026
- 5.3.2 Global Tacrolimus Capsules Revenue by Region: 2027-2032
- 5.4 North America Tacrolimus Capsules Market Facts & Figures by Country
- 5.4.1 North America Tacrolimus Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Tacrolimus Capsules Sales by Country (2021-2032)
- 5.4.3 North America Tacrolimus Capsules Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Tacrolimus Capsules Market Facts & Figures by Country
- 5.5.1 Europe Tacrolimus Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Tacrolimus Capsules Sales by Country (2021-2032)
- 5.5.3 Europe Tacrolimus Capsules Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Tacrolimus Capsules Market Facts & Figures by Country
- 5.6.1 Asia Pacific Tacrolimus Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Tacrolimus Capsules Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Tacrolimus Capsules Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Tacrolimus Capsules Market Facts & Figures by Country
- 5.7.1 South America Tacrolimus Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Tacrolimus Capsules Sales by Country (2021-2032)
- 5.7.3 South America Tacrolimus Capsules Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Tacrolimus Capsules Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Tacrolimus Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Tacrolimus Capsules Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Tacrolimus Capsules Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Tacrolimus Capsules Sales by Type (2021-2032)
- 6.1.1 Global Tacrolimus Capsules Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Tacrolimus Capsules Sales Market Share by Type (2021-2032)
- 6.2 Global Tacrolimus Capsules Revenue by Type (2021-2032)
- 6.2.1 Global Tacrolimus Capsules Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Tacrolimus Capsules Revenue Market Share by Type (2021-2032)
- 6.3 Global Tacrolimus Capsules Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Tacrolimus Capsules Sales by Application (2021-2032)
- 7.1.1 Global Tacrolimus Capsules Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Tacrolimus Capsules Sales Market Share by Application (2021-2032)
- 7.2 Global Tacrolimus Capsules Revenue by Application (2021-2032)
- 7.2.1 Global Tacrolimus Capsules Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Tacrolimus Capsules Revenue Market Share by Application (2021-2032)
- 7.3 Global Tacrolimus Capsules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Tacrolimus Capsules Value Chain Analysis
- 8.1.1 Tacrolimus Capsules Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Tacrolimus Capsules Production Mode & Process
- 8.2 Tacrolimus Capsules Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Tacrolimus Capsules Distributors
- 8.2.3 Tacrolimus Capsules Customers
9 Global Tacrolimus Capsules Analyzing Market Dynamics
- 9.1 Tacrolimus Capsules Industry Trends
- 9.2 Tacrolimus Capsules Industry Drivers
- 9.3 Tacrolimus Capsules Industry Opportunities and Challenges
- 9.4 Tacrolimus Capsules Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst